Antibodies directed against platelet factor 4 (PF4) are at the origin of two major clinical entities that are distinct but have strong clinical and biological similarities: heparin-induced thrombocytopenia (HIT) and vaccine-induced immune thrombosis and thrombocytopenia (VITT). The gene discussed is PF4; the disease is Thrombocytopenia.